SOPHiA GENETICS SA (SOPH)
4.60
-0.27
(-5.54%)
USD |
NASDAQ |
Dec 09, 16:00
4.615
+0.02
(+0.33%)
After-Hours: 20:00
SOPHiA GENETICS Profit Margin (Quarterly): -102.9% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 8.84% |
| AC Immune SA | -1.69K% |
| CRISPR Therapeutics AG | -11.97K% |
| Addex Therapeutics Ltd. | -3.18K% |
| NewCelX Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -86.58% |
| Return on Assets | -45.62% |
| Return on Invested Capital | -57.50% |
| Gross Profit Margin (Quarterly) | 66.32% |
| Operating Margin (Quarterly) | -88.76% |
| Return on Net Operating Assets | -111.3% |